The vaccine against hepatitis Twinrix is ​​often prescribed for people who are in need



[ad_1]

TORONTO – Canadian vaccine deficiencies that protect against hepatitis A and B, this winter could lead to considerable disadvantages for the travel plans of Canadian applicants for the sun.

Twinrix is ​​often prescribed to people who go to the southern sites where there is an increased risk of infection with viruses that attack the liver, but the vaccine is inadequate for both adults and children.

Hepatitis A is mostly transmitted through contaminated food and water. Most infected are completely cured without permanent damage to the liver, and in some cases the infection can lead to sudden liver failure.

Hepatitis B, a more serious disease that spreads widely across sex, can lead to a chronic infection that increases the risk of cirrhosis, liver failure and liver cancer.

The GlaxoSmithKline manufacturer says the vaccine production is a complex process that can last 10 to 26 months, and the product shortage can arise from unexpected queries, supply chain disruptions, or production issues.

GSK says Twinrix remains in a limited range of products, continuously working to restore the market. However, the company anticipates that the interference will continue until the vaccine stabilizes.

[ad_2]

Source link